NCT00536939 2020-09-24Trial of Paclitaxel, Bevacizumab, and Enzastaurin Versus Paclitaxel, Bevacizumab and Placebo for Breast CancerEli Lilly and CompanyPhase 2 Terminated2 enrolled 5 charts
NCT00437294 2020-08-10Enzastaurin in Combination of Capecitabine to Treat Breast CancerEli Lilly and CompanyPhase 2 Terminated86 enrolled 20 charts
NCT00451555 2019-11-01Enzastaurin Plus Fulvestrant vs. Placebo Plus Fulvestrant in Breast CancerEli Lilly and CompanyPhase 2 Completed156 enrolled 15 charts